Last edition
News about " CRISPR-Cas9 technology receives US patnet"
Merck's foundational CRISPR-Cas9 technology receives US patnet
Merck, a leading science and technology company, announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the United States
CRISPR-Cas9 Technology Receives US Patnet | 12/05/2020 | By Darshana | 461
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members